P17.32 EFFICACY AND TOLERABILITY OF BEVACIZUMAB MONOTHERAPY IN PATIENTS WITH PREVIOUSLY TREATED RECURRENT GLIOBLASTOMA MULTIFORME (GBM)

por Francini, E., Mazzaroppi, S., Salvati, M., Caponnetto, S., Laera, L., Migali, C., Bianco, V.
Publicado em 2014

The European Medicines Agency review of entrectinib for the treatment of adult or paediatric patients with solid tumours who have a neurotrophic tyrosine receptor kinase gene fusio...

por Delgado, J., Pean, E., Melchiorri, D., Migali, C., Josephson, F., Enzmann, H., Pignatti, F.
Publicado no ESMO Open (2021)

The EMA assessment of pembrolizumab as monotherapy for the first-line treatment of adult patients with metastatic microsatellite instability-high or mismatch repair deficient color...

por Trullas, A., Delgado, J., Genazzani, A., Mueller-Berghaus, J., Migali, C., Müller-Egert, S., Zander, H., Enzmann, H., Pignatti, F.
Publicado no ESMO Open (2021)